中 SFDA approves Medi-future’s Digital Mammography System

The only domestic women’s healthcare company MEDI-FUTURE, Inc. won the first China SFDA Approval for digital mammography among domestic companies, and has been ready to enter the China market.

'Bresitge' that is the first domestic digital mammography system for early detection of breast cancer, and it has been steadily recognized with excellent image quality of direct conversions and ergonomic design for user-friendly.  

Medi-Future is expected that its sales will be increased throughout SFDA approval, and it plans to attend upcoming 

CMEF(China Medical Equipment Fair) in October to embark on local marketing campaigns.   

The CEO of Medi-Fure inc, comments "Medi-Future has gone through complicated procedures and strict examinations 

to acquire China SFDA approval, so we could get some experience and Know-how for global sales" 

and also mentions " we will be focusing on penetrating into the China market".  

About MEDI-FUTURE, Inc

MEDI-FUTURE,Inc is a domestic only women’s healthcare company that strives to create the health and beauty of women around the world, also a global company leading the domestic and overseas medical equipments market with its excellent image processing technology and differentiated marketing strategy. It is growing rapidly, entering domestic major university hospitals with Asian, Middle Eastern, European and African markets. MEDI-FUTURE’s core products include Direct Digital X-ray Mammographic System, Stereotactic Biopsy System, Dedicated Breast MRI System, and Review Workstation etc. In addition, it is selected as Good Design(Ministry of Knowledge and Economy), World-Class Product(Ministry of Knowledge and Economy) and Columbus Project(Ministry of Health and Welfare).  

 MEDI-FUTURE is a global healthcare IT company dedicated to women's breast care.

 Create Women's Health and Beauty